SDC2 and pulmonary fibrosis: We have demonstrated that SDC2-mediated CD148 activation inhibits experimental lung fibrosis by regulating PI3K/Akt/mammalian target of rapamycin (mTOR) signaling, thereby increasing autophagy and decreasing levels of p62 and subsequent NF-κB inactivation27.